Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

517 ARTÍCULOS , VIENDO DEL 301 AL 315

ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan

Siemers E, Hitchcock J, Sundell K, Dean R, Jerecic J, Cline E, Iverson K, Moore J, Edgar C, Manber R, Fuin N, Poppe T, Barton R.

J Prev Alzheimers Dis. 2023;10(1):19-24. doi: 10.14283/jpad.2022.93.

Imaging Amyloid and Tau in the Retina: Current Research and Future Directions

Tang MY, Blazes MS, Lee CS.

J Neuroophthalmol. 2023 Jun 1;43(2):168-179. doi: 10.1097/WNO.0000000000001786. Epub 2023 Feb 3.

Association between anxiety symptoms and Alzheimer's disease biomarkers in cognitively healthy adults: A systematic review and meta-analysis

Demnitz-King H, Saba L, Lau Y, Munns L, Zabihi S, Schlosser M, Del-Pino-Casado R, Orgeta V, Marchant NL.

J Psychosom Res. 2023 Mar;166:111159. doi: 10.1016/j.jpsychores.2023.111159. Epub 2023 Jan 20.

A novel regulator in Alzheimer's disease progression: The astrocyte-derived extracellular vesicles

Li B, Ma Z, Li Z.

Ageing Res Rev. 2023 Apr;86:101871. doi: 10.1016/j.arr.2023.101871. Epub 2023 Feb 2.

Scientific, Ethical, and Practical Considerations for the Testing and Disclosure of Alzheimer Disease Biomarkers

McCusker EA, Loy CT.

Neurology. 2023 May 23;100(21):993-994. doi: 10.1212/WNL.0000000000207199. Epub 2023 Feb 15.

Challenges and opportunities of diagnostic markers of Alzheimer's disease based on structural magnetic resonance imaging

Hu X, Meier M, Pruessner J.

Brain Behav. 2023 Mar;13(3):e2925. doi: 10.1002/brb3.2925. Epub 2023 Feb 16.

CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab

Nisenbaum L, Martone R, Chen T, Rajagovindan R, Dent G, Beaver J, Rubel C, Racine A, He P, Harrison K, Dean R, Vandijck M, Haeberlein SB.

Alzheimers Dement. 2023 Aug;19(8):3379-3388. doi: 10.1002/alz.12919. Epub 2023 Feb 16.

Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: Convergence or divergence? Lessons from Alzheimer's disease and synucleinopathies

Sensi SL, Russo M, Tiraboschi P.

Handb Clin Neurol. 2023;192:187-218. doi: 10.1016/B978-0-323-85538-9.00015-8.

Association between primary care electrocardiogram markers and Alzheimer's disease

Isaksen JL, Ghouse J, Skov MW, Olesen MS, Holst AG, Pietersen A, Nielsen JB, Maier A, Graff C, Gerds TA, Frikke-Schmidt R, Kanters JK.

J Neurol Sci. 2023 Apr 15;447:120581. doi: 10.1016/j.jns.2023.120581. Epub 2023 Feb 9.

Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer's Disease

Rani S, Dhar SB, Khajuria A, Gupta D, Jaiswal PK, Singla N, Kaur M, Singh G, Barnwal RP.

Cell Mol Neurobiol. 2023 Aug;43(6):2491-2523. doi: 10.1007/s10571-023-01330-y. Epub 2023 Feb 27.

Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective

Shah J, Rahman Siddiquee MM, Krell-Roesch J, Syrjanen JA, Kremers WK, Vassilaki M, Forzani E, Wu T, Geda YE.

J Alzheimers Dis. 2023;92(4):1131-1146. doi: 10.3233/JAD-221261.

Advances in sample preparation and HPLC-MS/MS methods for determining amyloid-β peptide in biological samples: a review

de Souza ID, Queiroz MEC.

Anal Bioanal Chem. 2023 Jul;415(18):4003-4021. doi: 10.1007/s00216-023-04631-9. Epub 2023 Mar 6.

Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest

Ashton NJ, Moseby-Knappe M, Benedet AL, Grötschel L, Lantero-Rodriguez J, Karikari TK, Hassager C, Wise MP, Stammet P, Kjaergaard J, Friberg H, Nielsen N, Cronberg T, Zetterberg H, Blennow K.

JAMA Neurol. 2023 Apr 1;80(4):388-396. doi: 10.1001/jamaneurol.2023.0050.

Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist

Alcolea D, Beeri MS, Rojas JC, Gardner RC, Lleó A.

Neurology. 2023 Jul 25;101(4):172-180. doi: 10.1212/WNL.0000000000207193. Epub 2023 Mar 6.

Neurofilament light chain as neuronal injury marker - what is needed to facilitate implementation in clinical laboratory practice?

Arslan B, Zetterberg H.

Clin Chem Lab Med. 2023 Mar 7;61(7):1140-1149. doi: 10.1515/cclm-2023-0036. Print 2023 Jun 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias